119 related articles for article (PubMed ID: 38613884)
1. High mobility group box 1 mediates inflammatory responses in malignant peritoneal mesothelioma.
Wang L; Wang X; Sun N; Liu W
Int Immunopharmacol; 2024 May; 133():112039. PubMed ID: 38613884
[TBL] [Abstract][Full Text] [Related]
2. Malignant Peritoneal Mesothelioma: Characterization of the Inflammatory Response in the Tumor Microenvironment.
Judge S; Thomas P; Govindarajan V; Sharma P; Loggie B
Ann Surg Oncol; 2016 May; 23(5):1496-500. PubMed ID: 26545374
[TBL] [Abstract][Full Text] [Related]
3. Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma.
Tabata C; Shibata E; Tabata R; Kanemura S; Mikami K; Nogi Y; Masachika E; Nishizaki T; Nakano T
BMC Cancer; 2013 Apr; 13():205. PubMed ID: 23617783
[TBL] [Abstract][Full Text] [Related]
4. HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma.
Wang Y; Jiang Z; Yan J; Ying S
Dis Markers; 2019; 2019():4183157. PubMed ID: 30891101
[TBL] [Abstract][Full Text] [Related]
5. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
[TBL] [Abstract][Full Text] [Related]
6. Expression analysis of HMGB1 in histological samples of malignant pleural mesothelioma.
Rrapaj E; Trisolini E; Bertero L; Salvo M; Indellicato R; Andorno S; Garcia-Manteiga JM; Rena O; Boldorini RL
Histopathology; 2018 May; 72(6):1039-1050. PubMed ID: 29356044
[TBL] [Abstract][Full Text] [Related]
7. ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.
Cheng YY; Kirschner MB; Cheng NC; Gattani S; Klebe S; Edelman JJ; Vallely MP; McCaughan BC; Jin HC; van Zandwijk N; Reid G
J Thorac Oncol; 2013 Oct; 8(10):1317-28. PubMed ID: 24457242
[TBL] [Abstract][Full Text] [Related]
8. Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma.
Mogi A; Koga K; Aoki M; Hamasaki M; Uesugi N; Iwasaki A; Shirakusa T; Tamura K; Nabeshima K
Virchows Arch; 2013 Jan; 462(1):83-93. PubMed ID: 23187830
[TBL] [Abstract][Full Text] [Related]
9. Natural diterpenes from coffee, cafestol and kahweol induce apoptosis through regulation of specificity protein 1 expression in human malignant pleural mesothelioma.
Lee KA; Chae JI; Shim JH
J Biomed Sci; 2012 Jun; 19(1):60. PubMed ID: 22734486
[TBL] [Abstract][Full Text] [Related]
10. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
[TBL] [Abstract][Full Text] [Related]
11. Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays.
Chapel DB; Stewart R; Furtado LV; Husain AN; Krausz T; Deftereos G
Hum Pathol; 2019 May; 87():11-17. PubMed ID: 30794891
[TBL] [Abstract][Full Text] [Related]
12. CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome.
Ortolan E; Giacomino A; Martinetto F; Morone S; Lo Buono N; Ferrero E; Scagliotti G; Novello S; Orecchia S; Ruffini E; Rapa I; Righi L; Volante M; Funaro A
Oncotarget; 2014 Aug; 5(15):6191-205. PubMed ID: 25026285
[TBL] [Abstract][Full Text] [Related]
13. Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells.
Rao M; Atay SM; Shukla V; Hong Y; Upham T; Ripley RT; Hong JA; Zhang M; Reardon E; Fetsch P; Miettinen M; Li X; Peer CJ; Sissung T; Figg WD; De Rienzo A; Bueno R; Schrump DS
Clin Cancer Res; 2016 Mar; 22(5):1197-210. PubMed ID: 26459178
[TBL] [Abstract][Full Text] [Related]
14. Serum HMGB1 as a diagnostic marker for malignant peritoneal mesothelioma.
Tabata C; Kanemura S; Tabata R; Masachika E; Shibata E; Otsuki T; Nishizaki T; Nakano T
J Clin Gastroenterol; 2013 Sep; 47(8):684-8. PubMed ID: 23685846
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Numb suppresses tumor cell growth and enhances sensitivity to cisplatin in epithelioid malignant pleural mesothelioma.
Kang Y; Ding M; Tian G; Guo H; Wan Y; Yao Z; Li B; Lin D
Oncol Rep; 2013 Jul; 30(1):313-9. PubMed ID: 23624653
[TBL] [Abstract][Full Text] [Related]
16. miR-1 induces growth arrest and apoptosis in malignant mesothelioma.
Xu Y; Zheng M; Merritt RE; Shrager JB; Wakelee HA; Kratzke RA; Hoang CD
Chest; 2013 Nov; 144(5):1632-1643. PubMed ID: 23828229
[TBL] [Abstract][Full Text] [Related]
17. Repurposing clofazimine for malignant pleural mesothelioma treatment - In-vitro assessment of efficacy and mechanism of action.
Parvathaneni V; Chilamakuri R; Kulkarni NS; Wang X; Agarwal S; Gupta V
Life Sci; 2022 Oct; 306():120843. PubMed ID: 35908620
[TBL] [Abstract][Full Text] [Related]
18. Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma.
Borchert S; Suckrau PM; Walter RFH; Wessolly M; Mairinger E; Steinborn J; Hegedus B; Hager T; Herold T; Eberhardt WEE; Wohlschlaeger J; Aigner C; Bankfalvi A; Schmid KW; Mairinger FD
Sci Rep; 2020 Oct; 10(1):18677. PubMed ID: 33122816
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.
Pellegrini L; Xue J; Larson D; Pastorino S; Jube S; Forest KH; Saad-Jube ZS; Napolitano A; Pagano I; Negi VS; Bianchi ME; Morris P; Pass HI; Gaudino G; Carbone M; Yang H
Oncotarget; 2017 Apr; 8(14):22649-22661. PubMed ID: 28186988
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.
Laszlo V; Hoda MA; Garay T; Pirker C; Ghanim B; Klikovits T; Dong YW; Rozsas A; Kenessey I; Szirtes I; Grusch M; Jakopovic M; Samarzija M; Brcic L; Kern I; Rozman A; Popper H; Zöchbauer-Müller S; Heller G; Altenberger C; Ziegler B; Klepetko W; Berger W; Dome B; Hegedus B
J Pathol; 2015 Oct; 237(2):203-14. PubMed ID: 26011651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]